Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)-Reference-Cited by-同舟云学术

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

Published:2019-06 Issue: Volume:114 Page:55-66
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

McCartney Amelia^ORCID,Biagioni Chiara,Schiavon Gaia,Bergqvist Mattias,Mattsson Karin,Migliaccio Ilenia,Benelli Matteo,Romagnoli Dario,Bonechi Martina,Boccalini Giulia,Pestrin Marta,Galardi Francesca,De Luca Francesca,Biganzoli Laura,Piccart Martine,Gradishar William J.,Chia Stephen,Di Leo Angelo,Malorni Luca^ORCID

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients;McKenna;Br J Canc,1988

2. Breast tumour thymidine kinase levels and disease recurrence;O'Neill;Med Lab Sci,1992

3. Thymidine kinase 1 upregulation is an early event in breast tumor formation;Alegre;J Oncol,2012

4. The role of thymidine kinase in cancer diseases;Topolcan;Expert Opin Med Diagn,2008

5. Human thymidine kinase 1: regulation in normal and malignant cells;Munch-Petersen;Adv Enzym Regul,1995

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial;Breast Cancer Research and Treatment;2024-01-04

2. The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management;Cancers;2023-11-17

3. Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study;Cancers;2023-11-16

4. Highly enantio-stereoselective Ni-catalyzed reductive cyclization to cyclopentanes with chiral quaternary centres of trisubstituted allylic siloxanes;Green Synthesis and Catalysis;2023-09

5. Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners;Cell Metabolism;2023-06